Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
Titel:
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
Auteur:
Jacobsohn, David A. Loken, Michael R. Fei, Mingwei Adams, Alexia Brodersen, Lisa Eidenschink Logan, Brent R. Ahn, Kwang Woo Shaw, Bronwen E. Kletzel, Morris Olszewski, Marie Khan, Sana Meshinchi, Soheil Keating, Amy Harris, Andrew Teira, Pierre Duerst, Reggie E. Margossian, Steven P. Martin, Paul L. Petrovic, Aleksandra Dvorak, Christopher C. Nemecek, Eneida R. Boyer, Michael W. Chen, Allen R. Davis, Jeffrey H. Shenoy, Shalini Savasan, Sureyya Hudspeth, Michelle P. Adams, Roberta H. Lewis, Victor A. Kheradpour, Albert Kasow, Kimberly A. Gillio, Alfred P. Haight, Ann E. Bhatia, Monica Bambach, Barbara J. Haines, Hilary L. Quigg, Troy C. Greiner, Robert J. Talano, Julie-An M. Delgado, David C. Cheerva, Alexandra Gowda, Madhu Ahuja, Sanjay Ozkaynak, Mehmet Mitchell, David Schultz, Kirk R. Fry, Terry J. Loeb, David M. Pulsipher, Michael A.